Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Rock Springs Capital Management LP
Form 13F · Q2 2026

Rock Springs Capital Management LP

CIK 1595725申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$20.5亿
申报组合市值
104
持仓数量
12
Quarters on record
Top 50
持仓数量

Rock Springs Capital Management LP——持仓

共 104 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1RVMD Revolution Medicines Inc1.1M−8.6%$2.1亿10.1%
2TVTX Travere Therapeutics Inc2.2M+47.4%$1.2亿6.0%
3LLY Eli Lilly & Co98,700+0.0%$1.2亿5.8%
4MDGL Madrigal Pharmaceuticals Inc174,999+2.3%$9397万4.6%
5MIRM Mirum Pharmaceuticals Inc798,145−1.6%$9344万4.6%
6RYTM Rhythm Pharmaceuticals Inc692,598+0.4%$7690万3.8%
7KYMR Kymera Therapeutics Inc453,156−8.8%$5196万2.5%
8ARGX Argenx Se52,750−46.4%$4894万2.4%
9ASND Ascendis Pharma A/S168,750—$4501万2.2%
10XENE Xenon Pharmaceuticals Inc683,907−10.4%$4128万2.0%
11SRRK Scholar Rock Hldg Corp715,452−3.3%$3935万1.9%
12INSM Insmed Inc362,150+15.2%$3861万1.9%
13PEN Penumbra Inc115,750−3.9%$3655万1.8%
14GPCR Structure Therapeutics Inc640,317+0.0%$3437万1.7%
15RARE Ultragenyx Pharmaceutical In967,855−20.6%$3232万1.6%
16IRTC Irhythm Holdings Inc269,650+3.0%$3207万1.6%
17ISRG Intuitive Surgical Inc76,460−6.8%$3041万1.5%
18AGL Agilon Health Inc262,600+1.0%$2815万1.4%
19UNH Unitedhealth Group Inc63,750+20.3%$2650万1.3%
20CLDX Celldex Therapeutics Inc New699,146+7.5%$2602万1.3%
21ERAS Erasca Inc1.4M+27.1%$2569万1.3%
22NBIX Neurocrine Biosciences Inc144,750−3.8%$2440万1.2%
23ELVN Enliven Therapeutics Inc464,625−43.8%$2358万1.2%
24THC Tenet Healthcare Corp125,000+0.0%$2338万1.1%
25DXCM Dexcom Inc343,000−3.5%$2310万1.1%
26ACRS Aclaris Therapeutics Inc4.3M−3.2%$2291万1.1%
27MMED Minimed Group Inc1.5M+44.1%$2272万1.1%
28BSX Boston Scientific Corp528,500+2.6%$2256万1.1%
29PHVS Pharvaris N V648,333+0.4%$2242万1.1%
30AVLN Avalyn Pharmaceuticals Inc662,918—$2182万1.1%
31COAG Hemab Therapeutics Hldgs Inc575,432—$2114万1.0%
32DYN Dyne Therapeutics Inc942,154−3.1%$2093万1.0%
33ALNY Alnylam Pharmaceuticals Inc66,750−9.8%$2009万1.0%
34COGT Cogent Biosciences Inc515,917−17.3%$1997万1.0%
35AGIO Agios Pharmaceuticals Inc532,563−33.4%$1976万1.0%
36NAMS Newamsterdam Pharma Company582,744−1.0%$1975万1.0%
37VERA Vera Therapeutics Inc427,584−15.1%$1835万0.9%
38TARS Tarsus Pharmaceuticals Inc277,087+23.1%$1744万0.9%
39HTFL Heartflow Inc573,500+0.2%$1683万0.8%
40MBX Mbx Biosciences Inc298,218+3.6%$1646万0.8%
41CYTK Cytokinetics Inc187,980+314.4%$1601万0.8%
42BCAX Bicara Therapeutics Inc535,286+9.4%$1589万0.8%
43PBLS Parabilis Medicines Inc578,028—$1582万0.8%
44ZLAB Zai Lab Ltd814,707+0.0%$1548万0.8%
45DHR Danaher Corp Del76,300+24.1%$1453万0.7%
46TNGX Tango Therapeutics Inc456,551+18.0%$1427万0.7%
47EVH Evolent Health Inc2.5M−6.5%$1355万0.7%
48PTCT Ptc Therapeutics Inc162,298+0.3%$1324万0.6%
49MLYS Mineralys Therapeutics Inc484,951+10.3%$1308万0.6%
50ZBIO Zenas Biopharma Inc502,077+0.0%$1274万0.6%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。